The C-terminal transmembrane domain of Bcl-xL mediates changes in mitochondrial morphology
- PMID: 17766334
- PMCID: PMC2134878
- DOI: 10.1529/biophysj.107.104323
The C-terminal transmembrane domain of Bcl-xL mediates changes in mitochondrial morphology
Abstract
We investigate the effect of mitochondrial localization and the Bcl-x(L) C-terminal transmembrane (TM) domain on mitochondrial morphology and subcellular light scattering. CSM 14.1 cell lines stably expressed yellow fluorescent protein (YFP), YFP-Bcl-x(L,) YFP-Bcl-x(L)-DeltaTM, containing the remainder of Bcl-x(L) after deletion of the last 21 amino acids corresponding to the TM domain, or YFP-TM, consisting of YFP fused at its C-terminal to the last 21 amino acids of Bcl-x(L). YFP-Bcl-x(L) and YFP-TM localized to the mitochondria. Their expression decreased the intensity ratio of wide-to-narrow angle forward scatter by subcellular organelles, and correlated with an increase in the proportion of mitochondria with an expanded matrix having greatly reduced intracristal spaces as observed by electron microscopy. Cells expressing YFP-TM also exhibited significant autophagy. In contrast, YFP-Bcl-x(L)-DeltaTM was diffusely distributed in the cells, and its expression did not alter light scattering or mitochondrial morphology compared with parental cells. Expression of YFP-Bcl-x(L) or YFP-Bcl-x(L)-DeltaTM provided significant resistance to staurosporine-induced apoptosis. Surprisingly however, YFP-TM expression also conferred a moderate level of cell death resistance in response to staurosporine. Taken together, our results suggest the existence of a secondary Bcl-x(L) function that is mediated by the transmembrane domain, alters mitochondrial morphology, and is distinct from BH3 domain sequestration.
Figures







Similar articles
-
Alterations in the characteristic size distributions of subcellular scatterers at the onset of apoptosis: effect of Bcl-xL and Bax/Bak.J Biomed Opt. 2010 Jul-Aug;15(4):045002. doi: 10.1117/1.3462933. J Biomed Opt. 2010. PMID: 20799797
-
BCL-xL-dependent light scattering by apoptotic cells.Biophys J. 2004 Dec;87(6):4163-71. doi: 10.1529/biophysj.104.048736. Epub 2004 Sep 17. Biophys J. 2004. PMID: 15377529 Free PMC article.
-
Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains.Cell Death Differ. 2001 Sep;8(9):933-42. doi: 10.1038/sj.cdd.4400888. Cell Death Differ. 2001. PMID: 11526448
-
A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures.Metab Eng. 2003 Oct;5(4):230-45. doi: 10.1016/s1096-7176(03)00044-2. Metab Eng. 2003. PMID: 14642351
-
Characterization of the signal that directs Bcl-x(L), but not Bcl-2, to the mitochondrial outer membrane.J Cell Biol. 2003 Jan 6;160(1):53-64. doi: 10.1083/jcb.200210084. Epub 2003 Jan 6. J Cell Biol. 2003. PMID: 12515824 Free PMC article.
Cited by
-
OPTICAL COHERENCE TOMOGRAPHY AND HISTOLOGY OF AGE-RELATED MACULAR DEGENERATION SUPPORT MITOCHONDRIA AS REFLECTIVITY SOURCES.Retina. 2018 Mar;38(3):445-461. doi: 10.1097/IAE.0000000000001946. Retina. 2018. PMID: 29210936 Free PMC article. Review.
-
Enhanced transient recombinant protein production in CHO cells through the co-transfection of the product gene with Bcl-xL.Biotechnol J. 2014 Sep;9(9):1164-74. doi: 10.1002/biot.201300468. Epub 2014 May 8. Biotechnol J. 2014. PMID: 24604826 Free PMC article.
-
Protein oligomerization mediated by the transmembrane carboxyl terminal domain of Bcl-XL.FEBS Lett. 2011 Oct 3;585(19):2935-42. doi: 10.1016/j.febslet.2011.08.012. Epub 2011 Aug 16. FEBS Lett. 2011. PMID: 21856303 Free PMC article.
-
Microscopic imaging and spectroscopy with scattered light.Annu Rev Biomed Eng. 2010 Aug 15;12:285-314. doi: 10.1146/annurev-bioeng-061008-124811. Annu Rev Biomed Eng. 2010. PMID: 20617940 Free PMC article. Review.
-
The non-apoptotic action of Bcl-xL: regulating Ca(2+) signaling and bioenergetics at the ER-mitochondrion interface.J Bioenerg Biomembr. 2016 Jun;48(3):211-25. doi: 10.1007/s10863-016-9664-x. Epub 2016 May 7. J Bioenerg Biomembr. 2016. PMID: 27155879 Free PMC article.
References
-
- Danial, N. N., and S. J. Korsmeyer. 2004. Cell death: critical control points. Cell. 116:205–219. - PubMed
-
- Cory, S., and J. M. Adams. 2002. The BCL2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer. 2:647–656. - PubMed
-
- Muchmore, S. W., M. Sattler, H. Liang, R. P. Meadows, J. E. Harlan, H. S. Yoon, D. Nettesheim, B. S. Chang, C. B. Thompson, S. L. Wong, S.-C. Ng, and S. W. Fesik. 1996. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:335–341. - PubMed
-
- Sattler, M., H. Liang, D. Nettesheim, R. P. Meadows, J. E. Harlan, M. Eberstadt, H. S. Yoon, S. B. Shuker, B. S. Chang, A. J. Minn, C. B. Thompson, and S. W. Fesik. 1997. Structure of BCL-xL-Bak peptide complex: recognition between regulators of apoptosis. Science. 275:983–986. - PubMed
-
- Suzuki, M., R. J. Youle, and N. Tjandra. 2000. Structure of Bax. Coregulation of dimer formation and intracellular localization. Cell. 103:645–654. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials